Strategies for extended serum half-life of protein therapeutics
Top Cited Papers
- 1 December 2011
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 22 (6) , 868-876
- https://doi.org/10.1016/j.copbio.2011.06.012
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (KO1461/4)
This publication has 56 references indexed in Scilit:
- Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralizationNature Biotechnology, 2010
- Biopharmaceutical benchmarks 2010Nature Biotechnology, 2010
- Strategies to Extend Plasma Half-Lives of Recombinant AntibodiesBioDrugs, 2009
- Improving Therapeutic Properties of Protein Drugs through Alteration of Intracellular Trafficking PathwaysBiotechnology Progress, 2008
- The Impact of PEGylation on Biological TherapiesBioDrugs, 2008
- FcRn: the neonatal Fc receptor comes of ageNature Reviews Immunology, 2007
- How Does the Kidney Filter Plasma?Physiology, 2005
- Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomographyJournal of Clinical Investigation, 2004
- Pharmacokinetic aspects of biotechnology productsJournal of Pharmaceutical Sciences, 2004
- Rational cytokine design for increased lifetime and enhanced potency using pH-activated “histidine switching”Nature Biotechnology, 2002